Jilek et al. showed that the HLA-B*07:02-restricted EBV-specific (epitope spanning residues 379–387 of EBNA-3, EBVRPP, RPPIFIRRL) CD8+ T cell response is dysregulated in MS patients [29]. Here, CD8A is linked to myeloid sarcoma.